Skip to main content
. 2022 Aug 30;21:151. doi: 10.1186/s12904-022-01040-0

Table 1.

Participants’ characteristics (N = 114)

Disease type Total
(N = 114)
CHF
(n = 35)
Stroke
(n = 21)
ESRD
(n = 28)
ESLD
(n = 30)
Variables M ± SD/n (%) M ± SD/n (%) M ± SD/n (%) M ± SD/n (%) M ± SD/n (%)
Demographic characteristics
Age (years) 58.42 ± 15.59 61.94 ± 14.33 57.95 ± 16.50 59.29 ± 19.61 53.83 ± 11.09
  < 65 68 (59.6) 18 (51.4) 12 (57.1) 14 (40.0) 24 (80.0)
  ≥ 65 46 (40.4) 17 (48.6) 9 (42.9) 14 (50.0) 6 (20.0)
Sex
  Male 68 (59.6) 21 (60.0) 17 (81.0) 16 (57.1) 14 (46.7)
  Female 46 (40.4) 14 (40.0) 4 (19) 12 (42.9) 16 (53.3)
Spouse
  Yes 86 (75.4) 31 (88.6) 17 (81.0) 18 (64.3) 20 (66.7)
  No 28 (24.6) 4 (11.4) 4 (19.0) 10 (35.7) 10 (35.7)
Educational status
  ≤ Middle school 33 (28.9) 13 (37.1) 4 (19.0) 9 (32.1) 7 (23.3)
  High school 41 (36.0) 11 (31.4) 9 (42.9) 7 (25.0) 14 (46.7)
  ≥ College 40 (35.1) 11 (31.4) 8 (38.1) 12 (42.9) 9 (30.0)
Primary caregiver
  Spouse 63 (55.3) 20 (57.1) 11 (52.4) 16 (57.1) 16 (53.3)
  Parents 14 (12.3) 2 (5.7) 3 (14.3) 4 (14.3) 5 (16.7)
  Child(ren) 23 (20.2) 9 (25.7) 4 (19.0) 3 (10.7) 7 (23.3)
  Other 14 (12.3) 4 (11.4) 3 (14.3) 5 (17.9) 2 (6.7)
Working status
  Unemployed 54 (47.4) 20 (57.1) 6 (28.6) 18 (64.3) 10 (33.3)
  Employed 60 (52.6) 15 (42.9) 15 (71.4) 10 (35.7) 20 (66.7)
Family monthly income (USD)
  < 3500 73 (64.0) 23 (65.7) 11 (52.4) 21 (75.0) 18 (60.0)
  ≥ 3500 41 (36.0) 12 (34.3) 10 (47.6) 7 (25.0) 12 (40.0)
Religion
  None 41 (36.0) 11 (31.4) 8 (38.1) 13 (46.4) 9 (30.0)
  Catholicism/Christianity 41 (36.0) 11 (31.4) 7 (33.3) 9 (32.1) 14 (46.7)
  Buddhism 32 (28.1) 13 (37.1) 6 (28.6) 6 (21.4) 7 (23.3)
Hospice experience
  Yes 4 (3.5) 0 (0.0) 1 (4.8) 1 (3.6) 2 (6.7)
  No 110 (96.5) 35 (100.0) 20 (96.4) 27 (93.4) 28 (93.3)
Clinical characteristics
  Hospitalisation period (days) 7.98 ± 8.80 7.57 ± 7.64 6.00 ± 3.07 8.25 ± 8.62 9.60 ± 12.33
  < 7 days 69 (60.5) 22 (62.9) 14 (66.7) 15 (53.6) 18 (60.0)
  ≥ 7 days 45 (39.5) 13 (37.1) 7 (33.3) 13 (46.4) 12 (40.0)
  Number of comorbidities 3.14 ± 1.98 3.94 ± 2.56 1.67 ± 1.24 3.21 ± 1.34 3.17 ± 1.58
  ≤ 3 74 (64.9) 16 (45.7) 21 (100.0) 16 (57.1) 21 (70.0)
  > 3 40 (35.1) 19 (54.3) 0 (0.0) 12 (42.9) 9 (30.0)
Duration of disease (months)
  < 12 76 (66.7) 19 (54.3) 20 (95.2) 22 (78.6) 15 (50.0)
  ≥ 12 38 (33.3) 16 (45.7) 1 (4.8) 6 (21.4) 15 (50.0)
ECOG PS
  0, 1 68 (59.6) 18 (51.4) 13 (62.0) 13 (46.4) 24 (80.0)
  2 23 (20.2) 12 (34.3) 4 (19.0) 3 (10.7) 4 (13.3)
  3, 4 23 (20.2) 5 (14.3) 4 (19.0) 12 (42.9) 2 (6.7)

M mean, SD standard deviation, CHF chronic heart failure, ESRD end-stage renal disease, ESLD end-stage liver disease, ECOG PS Eastern Cooperative Oncology Group Performance Status